Crosspoint Therapeutics

Raised $2.5M in a Pre-Series A round, announced 4 March 2026.

Latest round Pre-Series ACountry South KoreaSector Health

Round

Funds monkey toxicology study of lead EGFR ADC CPA-001

Amount: $2.5M
Stage: Pre-Series A
Announced: 4 March 2026
Lead: Qudus Ventures
Other investors: Sue Investment, Y-Biologics, BMI Korea
Use of funds: Funds monkey toxicology study of lead EGFR ADC CPA-001
Checked: Amount and date checked against the press source
Source: Crosspoint Therapeutics raises ₩3.6B pre-Series A (date approx) startuprecipe.co.kr

Antibody-drug conjugates using Fc-silencing Stealth-Body platform

How much has Crosspoint Therapeutics raised?

Crosspoint Therapeutics raised $2.5M in a Pre-Series A round, announced on 4 March 2026.

Who invested in Crosspoint Therapeutics?

Qudus Ventures led. Investors include Qudus Ventures, Sue Investment, Y-Biologics and BMI Korea.